544 related articles for article (PubMed ID: 20007582)
1. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
4. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
7. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
[TBL] [Abstract][Full Text] [Related]
9. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
[TBL] [Abstract][Full Text] [Related]
10. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
[TBL] [Abstract][Full Text] [Related]
13. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
Canault M; Peiretti F; Poggi M; Mueller C; Kopp F; Bonardo B; Bastelica D; Nicolay A; Alessi MC; Nalbone G
J Pathol; 2008 Apr; 214(5):574-83. PubMed ID: 18247429
[TBL] [Abstract][Full Text] [Related]
14. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
[TBL] [Abstract][Full Text] [Related]
15. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.
Okiyama N; Sugihara T; Iwakura Y; Yokozeki H; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Aug; 60(8):2505-12. PubMed ID: 19644888
[TBL] [Abstract][Full Text] [Related]
18. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
19. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
[TBL] [Abstract][Full Text] [Related]
20. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
